Serum and urinary aluminum levels in patients receiving alum-precipitated allergenic extracts.
Indications of aluminum (Al) loading and possible toxicity were sought on three occasions in each of six otherwise healthy patients on maintenance therapy with alum-precipitated allergenic extracts. As compared with age-matched controls receiving conventional aqueous immunotherapy, alum-treated patients had slightly higher levels of serum and urinary Al, suggesting slightly increased body burdens. Neither serum Al levels nor calculated urinary aluminum:creatinine ratios fell outside the broad normal ranges currently accepted for these determinations. Furthermore, no patient showed laboratory or clinical evidence of aluminum toxicity.